The quality of vision is determined by two main factors: (a) the quality of the image that is transferred from the eye, and (b) the neural processing in the brain. Despite this fundamental fact, the eyecare industry focuses almost solely on bending light rays and restoring the anatomy of the eye, while the back end of the visual system – the visual cortex, is mostly neglected.
In the past three decades, there is growing evidence for the ability to substantially improve vision by visually stimulating the visual cortex using perceptual learning techniques. Clinical observations1 and experimental evidence2 indicate the presence of residual neural plasticity well after the critical period.
The first perceptual learning software to receive an FDA-clearance for the treatment of amblyopia beyond childhood (age 9-55) is RevitalVision (previously NeuroVision). The software uses dedicated algorithms to map the patient’s specific cortical deficits and to tailor specific stimulation programs to match these deficits. The specific neurons are targeted with an effective stimulus that induces a high neural response: the Gabor Patch3. This high response is further facilitated by the use of a proprietary Lateral Masking technique, in which three stimuli are arranged in a specific order to yield a significantly higher response than a single stimulus4. Repetitive strong neural response forms new neural connections at the synapse level, which leads to improved neural processing efficiency.
Four5-8 published randomized controlled trials (RCT’s) demonstrated similar clinical outcomes in adults with amblyopia with an average improvement of 2+ ETDRS lines, a 100% increase in contrast sensitivity function (CSF), and improvement in stereo acuity and binocular functions. Two single-arm studies demonstrated improvement beyond occlusion in children with amblyopia (age 7-8)9 and in adults with amblyopia (age 8-48)10
An additional algorithm of the same software was proven effective in enhancing uncorrected vision in patients with a minor refractive error; low myopia11 and early presbyopia12 enabling better vision without glasses. The algorithm was later proven effective in enhancing VA and CSF in post cataract13 and post refractive surgery patients14, who are challenged with low contrast sensitivity, difficulty to neuro-adapt, and side effects such as halo and glare. Clinical observations14 demonstrated that low CSF following cataract surgery can exist in emmetropic patients with good VA, which explains the term “unhappy 20/20 vision patients”.
Recently, two prospective RCT’s evaluated the efficacy of RevitalVision software in improving vision in congenital nystagmus patients15 and in patients with stable keratoconus post-crossed linking16. Both studies demonstrated significant improvement in VA as well as contrast sensitivity and binocular vision, offering hope to millions of patients with these conditions who are currently lacking effective treatments.
A Stargardt disease study17 and an AMD study18 suggest that retinal disease patients can also benefit from the same vision improvement effect.
Today, the key to optimizing visual functions lies in addressing the brain as well as the eyes!
Author: Yonina Thee, Certified Optometrist M. Optom.
References: